Recent Company News

• 08:26 AM ET Jun 24, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:14 AM ET Aug 25, 2026
  

  AgomAb Therapeutics NV initiated overweight at Piper Sandler ($12.82, 0.00)

• 04:18 PM ET Jun 24, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 06:13 AM ET Aug 19, 2026
  

  AgomAb Therapeutics NV initiated overweight at Cantor Fitzgerald ($13.73, 0.00)

• 04:48 PM ET Aug 06, 2026
  

  AgomAb Therapeutics NV reports H1 EPS (€0.80) vs FactSet €1.03 [1 est] ($13.50, 0.00)

• 08:01 AM ET Jul 23, 2026
  

  AgomAb Therapeutics NV initiated buy at B Riley Securities ($11.60, 0.00)